FDA Approved: CATAPRES-TTS-1 — Supplemental Application (Technomed Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CATAPRES-TTS-1, the clonidine transdermal system, from Technomed Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CATAPRES-TTS-1 (Clonidine transdermal system)

Snippet

SUPPL AP for CATAPRES-TTS-1 (CLONIDINE TRANSDERMAL SYSTEM)